D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$667M |
| 2 |
NVIDIA
NVDA
|
+$584M |
| 3 |
ConocoPhillips
COP
|
+$432M |
| 4 |
Amazon
AMZN
|
+$418M |
| 5 |
Johnson & Johnson
JNJ
|
+$377M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$836M |
| 2 |
Meta Platforms (Facebook)
META
|
+$525M |
| 3 |
Apple
AAPL
|
+$453M |
| 4 |
CELG
Celgene Corp
CELG
|
+$349M |
| 5 |
Pfizer
PFE
|
+$306M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.58% |
| 2 | Consumer Discretionary | 13.65% |
| 3 | Healthcare | 12.98% |
| 4 | Industrials | 7.3% |
| 5 | Financials | 7.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FOLD
601
DELISTED
Amicus Therapeutics
FOLD
| $26.8M | 0.03% |
2,147,403
+1,146,777
| +115% | +$14.6M |
|
602
NCR Voyix
VYX
$1.13B
| $26.7M | 0.03% |
1,400,317
-186,560
| -12% | -$3.47M |
|
|
AIV
603
Aimco
AIV
$377M
| $26.7M | 0.03% |
4,001,487
+2,418,159
| +153% | +$16.2M |
|
|
MRC
604
DELISTED
MRC Global
MRC
| $26.6M | 0.03% |
1,553,748
-596,153
| -28% | -$10M |
|
605
Teva Pharmaceuticals
TEVA
$36.2B
| $26.6M | 0.03% |
2,877,537
+2,671,960
| +1,300% | +$32.2M |
|
606
Williams-Sonoma
WSM
$27.6B
| $26.6M | 0.03% |
817,034
-15,380
| -2% | -$441K |
|
|
TVTY
607
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $26.5M | 0.03% |
1,611,396
-784,750
| -33% | -$15.1M |
|
608
CALL
Advanced Micro Devices
AMD
$807B
| $26.4M | 0.03% |
870,100
-106,800
| -11% | -$3.05M |
|
609
CALL
American Airlines Group
AAL
$9.9B
| $26.4M | 0.03% |
809,800
-122,700
| -13% | -$3.96M |
|
610
CALL
General Motors
GM
$78.7B
| $26.4M | 0.03% |
685,200
-404,700
| -37% | -$15.2M |
|
611
CALL
Kraft Heinz
KHC
$31.1B
| $26.4M | 0.03% |
850,500
+518,000
| +156% | +$16.3M |
|
612
Planet Fitness
PLNT
$4.29B
| $26.4M | 0.03% |
364,325
-49,736
| -12% | -$3.75M |
|
613
Workiva
WK
$3.13B
| $26.3M | 0.03% |
453,069
+154,746
| +52% | +$8.29M |
|
614
Trinity Industries
TRN
$2.95B
| $26.3M | 0.03% |
1,267,304
+284,942
| +29% | +$6.06M |
|
|
EQC
615
DELISTED
Equity Commonwealth
EQC
| $26.2M | 0.03% |
805,669
+341,800
| +74% | +$11.1M |
|
616
CALL
PepsiCo
PEP
$191B
| $26M | 0.03% |
198,300
-46,000
| -19% | -$5.9M |
|
617
Progress Software
PRGS
$1.59B
| $26M | 0.03% |
595,180
+5,593
| +0.9% | +$242K |
|
618
Kulicke & Soffa
KLIC
$5.14B
| $25.9M | 0.03% |
1,150,548
-74,535
| -6% | -$1.64M |
|
|
HMSY
619
DELISTED
HMS Holdings Corp.
HMSY
| $25.8M | 0.03% |
797,207
-314,615
| -28% | -$9.62M |
|
620
Henry Schein
HSIC
$9.64B
| $25.8M | 0.03% |
368,519
+229,985
| +166% | +$15.2M |
|
621
Nomad Foods
NOMD
$1.67B
| $25.6M | 0.03% |
1,200,818
+882,812
| +278% | +$18.5M |
|
|
CERN
622
DELISTED
Cerner Corp
CERN
| $25.6M | 0.03% |
349,803
+170,389
| +95% | +$11.5M |
|
623
Heron Therapeutics
HRTX
$86.9M
| $25.5M | 0.03% |
1,372,291
-99,305
| -7% | -$1.98M |
|
624
DuPont de Nemours
DD
$18.9B
| $25.4M | 0.03% |
269,092
-196,429
| -42% | -$23.5M |
|
625
CenterPoint Energy
CNP
$28.8B
| $25.3M | 0.03% |
885,174
+470,850
| +114% | +$14M |
|
Similar funds
D.E. Shaw & Co's Q2 2019 Portfolio in Review
As of Q2 2019, D.E. Shaw & Co held 4,048 positions worth $80.2B, up 3.6% from $77.4B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
D.E. Shaw & Co's Q2 2019 filing shows 499 new, 1,419 increased, 1,452 reduced and 416 closed positions. Its largest new stake was Zayo Group Holdings, Inc.: 5,926,898 shares worth $195M. The largest sale was Qualcomm, an estimated $836M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q2 2019 buy was Zayo Group Holdings, Inc.: 5,926,898 shares worth $195M.
- D.E. Shaw & Co added most to Alibaba in Q2 2019, an estimated $667M increase.
- D.E. Shaw & Co's biggest Q2 2019 reduction was Qualcomm, cutting an estimated $836M.
- D.E. Shaw & Co fully exited iShares Core S&P 500 ETF in Q2 2019, selling an estimated $42.7M.
- D.E. Shaw & Co's ten largest holdings make up 9.8% of its $80.2B portfolio in Q2 2019.
- D.E. Shaw & Co opened 499 new positions and closed 416 in Q2 2019.
- D.E. Shaw & Co's portfolio value rose 3.6% quarter-over-quarter to $80.2B.
Based on D.E. Shaw & Co's 13F filing for Q2 2019, filed 14 Aug 2019.